PAR 0.00% 25.5¢ paradigm biopharmaceuticals limited..

Hi Hamman,No is the short answer.Certainly another inflammatory...

  1. 4,252 Posts.
    lightbulb Created with Sketch. 6740
    Hi Hamman,


    No is the short answer.

    Certainly another inflammatory condition that iPPS could potentially address.

    Inflammatory Bowel Disease (IBD) is the overarching condition under which diseases such as Chron's disease falls. There is definitely some real chance that iPPS can address Chron's disease which I've come across in the past thus by extrapolation, IBD being another inflammatory condition also should be a possible future indication for us.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
0.000(0.00%)
Mkt cap ! $89.19M
Open High Low Value Volume
26.0¢ 26.0¢ 25.0¢ $110.6K 431.0K

Buyers (Bids)

No. Vol. Price($)
3 94172 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 30859 5
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.